 |
|
| code | 4523Market
| TYO1, OSA1Category
of Business | Pharmaceutical |
Inquiry : 4-6-10, Koishikawa, Bunkyo-ku, Tokyo 112-8088
[Official Homepage]
TEL : 03-3817-3700 |
 |
Corporate Presentation |
 |
|
|
|
|
| 1Q FY2008(Fiscal Year Ending March 31, 2009) Financial Results Presentation |
|
|
|
|
|
President and CEO Haruo Naito
|
|
|
|
|
|
|
|
|
|
| FY2007 Financial Results Presentation |
|
|
|
|
|
President and CEO Haruo Naito
|
|
|
|
|
|
|
|
|
|
| Outline of Accounting for Business Combination Associated with MGI PHARMA Acquisition and Revision of Earnings Forecasts for FY2007 |
|
|
|
|
|
President and CEO Haruo Naito
Executive Vice President and CFO Hideaki Matsui
|
|
|
|
|
|
|
|
|
|
| Information Meeting (March 4, 2008) |
|
|
|
|
|
President and CEO Haruo Naito
|
|
|
|
|
|
|
| Precautions in use |
 |
|
Nomura
IR assumes no responsibility for correctness, validity or
any other nature of the contents on this server.
No act such as alteration, modification or addition to the
contents is permitted.
Since the contents on this server are not intended to solicit
investment, our company has no liability for any trouble related
to investment made by any audience based on the contents of
this site. Investors are required to decide at their own discretion.
Nomura IR assumes no responsibility for correctness, validity
or any other nature of information, including its format and
details, obtained from any site linked from our site. |
|
|
|
|
|
